Patents Assigned to Aldexa Therapeutics, Inc.
  • Compositions and methods of treating retinal disease
    Patent number: 8940721
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: January 27, 2015
    Assignee: Aldexa Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 8940764
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: January 27, 2015
    Assignee: Aldexa Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala